Please use this identifier to cite or link to this item: http://10.1.7.192:80/jspui/handle/123456789/9779
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPatel, Riddhi M.-
dc.date.accessioned2021-02-12T08:56:20Z-
dc.date.available2021-02-12T08:56:20Z-
dc.date.issued2020-05-
dc.identifier.urihttp://10.1.7.192:80/jspui/handle/123456789/9779-
dc.descriptionGuided by Dr. Mohit Shahen_US
dc.description.abstractChemotherapy has become the primary therapeutic technique for cancer sufferers, although, rate of success remains poor, primarily due to cancer tissue's restricted availability of medication, some intolerable efficacy, multidrug tolerance growth, as well as the increasing cancer's complex homogeneous biology. Enhanced knowledge to tumors pathology into recent times including latest optimized approaches to drug delivery which is being pursued utilizing exceptional nanosystem as well as bioconjugate resource optimism for effective cancer therapy growth.en_US
dc.publisherInstitute of Pharmacy, Nirma University, A'baden_US
dc.relation.ispartofseriesPPR01023;-
dc.subjectPPR01023en_US
dc.subjectB. Pharm Project Reporten_US
dc.subjectPharmaceuticsen_US
dc.subjectCanceren_US
dc.subjectChemotherapyen_US
dc.subjecttumors pathologyen_US
dc.subjectnanosystemen_US
dc.titleTargeted Drug Delivery in Cancer Therapyen_US
dc.typeProject Reporten_US
Appears in Collections:B. Pharm Project Reports

Files in This Item:
File Description SizeFormat 
PPR01023.pdfPPR010231.15 MBAdobe PDFThumbnail
View/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.